Abstract:OBJECTIVE: To examine potential interactions between abdominal obesity, endocrine, metabolic and hemodynamic perturbations.SUBJECTS: A subgroup of 284 men from a population sample of 1040 at the age of 51 y.MEASUREMENTS: Anthropometric measurements included body mass index (BMI, kg/m2), waist/hip circumference ratio (WHR) and abdominal sagittal diameter (D). Endocrine measurements were a modified, low dose (0.5 mg) dexamethasone suppression test (Dex), testosterone (T) and insulin-like growth factor I (IGF-I). Overnight fasting values of blood glucose, serum insulin, triglycerides, total, low and high density lipoprotein cholesterol, as well as resting heart rate and blood pressure were also determined.RESULTS: Arbitrary subdivisions of the men were performed to obtain subgroups of low T and IGF-I values (lowest decile, borderlines ≤13.13 nmol/l and ≤128.80 μ <$>\kern-4.5 <$>μg/l, respectively) and normal or blunted Dex. Significant relationships with BMI, WHR or D, and abnormal metabolic and hemodynamic factors, usually with the exception of total and low density lipoprotein cholesterol, were then found in subgroups with different endocrine profiles. These included men with a blunted Dex test with low T or IGF-I values, as well as men with a normal Dex test and low or normal T or IGF-I values. In addition, a group with isolated low Dex suppression, as well as another group without endocrine abnormalities, showed such relationships. These findings suggest that, in men, obesity factors are associated with metabolic and hemodynamic complications with or without the presence of perturbations of hypothalamic-pituitary-adrenal axis (HPA) regulation or low T or growth hormone secretion.In order to generate hypotheses concerning the nature of the impact of the endocrine perturbations in abdominal obesity and its metabolic complications, path analyses were performed, testing different models. These models included the endocrine measurements (Dex test, T and IGF-I), the WHR and D (representing abdominal distribution of fat), BMI (representing obesity), as well as insulin and triglyceride values (representing metabolic perturbations). The results showed a satisfactory fit (goodness-of-fit index: 0.945 – 1.0) for the path diagrams: Dex → T/IGF-I → WHR or D → insulin → triglycerides with additional direct input of blunted Dex on insulin values (see ). With BMI as determinant, essentially the same results were found with the addition of a direct pathway between Dex and BMI as well as between IGF-I-T and insulin (). There was no evidence for pathways where WHR or BMI determined endocrine variables.CONCLUSIONS: The results suggest that abdominal obesity with or without endocrine abnormalities exerts a major impact on abnormalities in metabolic and hemodynamic variables. Abdominal obesity seems to be dependent on endocrine abnormalities, which in turn show direct or indirect relationships to the metabolic and circulatory variables, including a direct pathway between HPA-axis perturbations and accumulation of total body fat as indicated by the BMI.It is therefore suggested that endocrine perturbations are followed by obesity and by storage of an elevated proportion of fat in visceral depots, followed by metabolic and hemodynamic abnormalities. This is statistical evidence which is supported by evidence of mechanistic links in previous studies, suggesting the possibility of causal relationships. The results also indicate subgroups of abdominal obesity and its associated metabolic and hemodynamic abnormalities, which might be due to the input of different pathogenetic factors.

The Baro-Adrenal Axis

The Barocene Era

The octagon of opportunities in obesity

Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: A systematic review

Single-cell Molecular Profiling of All Three Components of the HPA Axis Reveals Adrenal ABCB1 As a Regulator of Stress Adaptation

Obesity, aldosterone excess, and mineralocorticoid receptor activation: Parallel or intersected circumstances?

Obesity as a Neuroendocrine Disorder

Obesity Associated Reproductive and Sexual Syndrome(OARS) in Men

Association of Obesity and Severe Asthma in Adults

Immunoneuroendocrine, Stress, Metabolic, and Behavioural Responses in High-Fat Diet-Induced Obesity

Assessment of Possible Role of Renin Angiotensin Aldosterone System in Obesity: Review Article

The Role of the Melanocortin System in Metabolic Disease: New Developments and Advances

Psychiatric Aspects of Obesity: A Narrative Review of Pathophysiology and Psychopathology

Adipose tissue in cortisol excess: What Cushing's syndrome can teach us?

The interactions between hypothalamic-pituitary-adrenal axis activity, testosterone, insulin-like growth factor I and abdominal obesity with metabolism and blood pressure in men

Cortisol, Stress, and Disease—Bidirectional Associations; Role for Corticosteroid-Binding Globulin?

Hypothalamic-pituitary-adrenal Axis in Postmenopausal Women with Type 2 Diabetes Mellitus and Visceral Obesity

Is there an association of cortisol, DHEA-S and cortisol/DHEA-S ratio with obesity and selected metabolic parameters?

Obesity I: Overview and molecular and biochemical mechanisms

Cortisol and the polycystic ovary syndrome

Blood Spotlight on Leukocytes and Obesity.